AHR and colonic neoplasm: Thus, in the context of existing colonic tumors, the presence of M. morganii-producing indolimines could contribute to AHR activation in combination with other tryptophan metabolites, such as kynurenine, in the intestinal tumor microenvironment, likely leading to enhanced tumor outgrowth and immune suppression.